Evidence map›Paper›PMID 25014110›Full record

ArticlePloS one2014

Combined NADPH oxidase 1 and interleukin 10 deficiency induces chronic endoplasmic reticulum stress and causes ulcerative colitis-like disease in mice.

Xavier Tréton, Eric Pedruzzi, Cécile Guichard, Yannick Ladeiro, Shirin Sedghi, Mélissa Vallée, Neike Fernandez, Emilie Bruyère, Paul-Louis Woerther, Robert Ducroc and 10 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. ROS in gastrointestinal inflammation: Rescue Or Sabotage?British journal of pharmacology · 2017
    Review
  12. Therapeutic potential of NADPH oxidase 1/4 inhibitors.British journal of pharmacology · 2017
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Defects in NADPH Oxidase GenesCellular and molecular gastroenterology and hepatology · 2015
    Article
  18. Review
  19. Review
  20. Gut microbes
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 8 institutions in 1 country.

Xavier TrétonINSERM, UMRS1149, Team «Physiopathology of Inflammatory Bowel Diseases», Centre de Recherche sur l'Inflammation, Paris, France; Université Paris-Diderot Sorbonne Paris-Cité, Paris, France; Service de Gastroentérologie et d'Assistance Nutritive, PMAD Hôpital Beaujon, Clichy la Garenne, France; Laboratory of Excellence Labex INFLAMEX, PRES Paris Sorbonne Cité, France.
Eric PedruzziINSERM, UMRS1149, Team «Physiopathology of Inflammatory Bowel Diseases», Centre de Recherche sur l'Inflammation, Paris, France; Université Paris-Diderot Sorbonne Paris-Cité, Paris, France; Laboratory of Excellence Labex INFLAMEX, PRES Paris Sorbonne Cité, France.
Cécile GuichardUniversité Paris-Diderot Sorbonne Paris-Cité, Paris, France; INSERM, UMRS871, Centre Biomédical des Cordeliers, Paris, France.
Yannick LadeiroINSERM, UMRS1149, Team «Physiopathology of Inflammatory Bowel Diseases», Centre de Recherche sur l'Inflammation, Paris, France; Université Paris-Diderot Sorbonne Paris-Cité, Paris, France; Laboratory of Excellence Labex INFLAMEX, PRES Paris Sorbonne Cité, France.
Shirin SedghiINSERM, UMRS1149, Team «Physiopathology of Inflammatory Bowel Diseases», Centre de Recherche sur l'Inflammation, Paris, France; Université Paris-Diderot Sorbonne Paris-Cité, Paris, France; Laboratory of Excellence Labex INFLAMEX, PRES Paris Sorbonne Cité, France.
Mélissa ValléeINSERM, UMRS1149, Team «Physiopathology of Inflammatory Bowel Diseases», Centre de Recherche sur l'Inflammation, Paris, France; Université Paris-Diderot Sorbonne Paris-Cité, Paris, France; Laboratory of Excellence Labex INFLAMEX, PRES Paris Sorbonne Cité, France.
Neike FernandezINSERM, UMRS1149, Team «Physiopathology of Inflammatory Bowel Diseases», Centre de Recherche sur l'Inflammation, Paris, France; Université Paris-Diderot Sorbonne Paris-Cité, Paris, France; Laboratory of Excellence Labex INFLAMEX, PRES Paris Sorbonne Cité, France.
Emilie BruyèreINSERM, UMR837, Team 5 «Mucins, epithelial differentiation and carcinogenesis», Jean-Pierre Aubert Research Center, Lille, France.
Paul-Louis WoertherLaboratoire de Bacteriologie, Hôpital Bichat-Claude Bernard, Paris, France.
Robert DucrocINSERM, UMRS1149, Team «Physiopathology of Inflammatory Bowel Diseases», Centre de Recherche sur l'Inflammation, Paris, France; Université Paris-Diderot Sorbonne Paris-Cité, Paris, France; Laboratory of Excellence Labex INFLAMEX, PRES Paris Sorbonne Cité, France.
Nicolas MontcuquetINSERM, U989, Université Paris-Descartes, Necker, Paris, France; Université Paris Descartes, Faculté de Médecine René Descartes, Paris, France.
Jean-Noel FreundINSERM, U682, Université Louis Pasteur, Strasbourg, France.
Isabelle Van SeuningenINSERM, UMR837, Team 5 «Mucins, epithelial differentiation and carcinogenesis», Jean-Pierre Aubert Research Center, Lille, France.
Frédérick BarreauUniversité Paris-Diderot Sorbonne Paris-Cité, Paris, France; Laboratory of Excellence Labex INFLAMEX, PRES Paris Sorbonne Cité, France; INSERM, U843 Hôpital R. Debré, Paris, France.
Assiya MarahINSERM, UMRS1149, Team «Physiopathology of Inflammatory Bowel Diseases», Centre de Recherche sur l'Inflammation, Paris, France; Université Paris-Diderot Sorbonne Paris-Cité, Paris, France; Service de Gastroentérologie et d'Assistance Nutritive, PMAD Hôpital Beaujon, Clichy la Garenne, France; Laboratory of Excellence Labex INFLAMEX, PRES Paris Sorbonne Cité, France.
Jean-Pierre HugotUniversité Paris-Diderot Sorbonne Paris-Cité, Paris, France; Laboratory of Excellence Labex INFLAMEX, PRES Paris Sorbonne Cité, France; INSERM, U843 Hôpital R. Debré, Paris, France.
Dominique Cazals-HatemINSERM, UMRS1149, Team «Physiopathology of Inflammatory Bowel Diseases», Centre de Recherche sur l'Inflammation, Paris, France; Université Paris-Diderot Sorbonne Paris-Cité, Paris, France; Laboratory of Excellence Labex INFLAMEX, PRES Paris Sorbonne Cité, France; Service d'Anatomo-Pathologie, Hôpital Beaujon, Clichy, France.
Yoram BouhnikINSERM, UMRS1149, Team «Physiopathology of Inflammatory Bowel Diseases», Centre de Recherche sur l'Inflammation, Paris, France; Université Paris-Diderot Sorbonne Paris-Cité, Paris, France; Service de Gastroentérologie et d'Assistance Nutritive, PMAD Hôpital Beaujon, Clichy la Garenne, France; Laboratory of Excellence Labex INFLAMEX, PRES Paris Sorbonne Cité, France.
Fanny DanielINSERM, UMRS1149, Team «Physiopathology of Inflammatory Bowel Diseases», Centre de Recherche sur l'Inflammation, Paris, France; Université Paris-Diderot Sorbonne Paris-Cité, Paris, France; Laboratory of Excellence Labex INFLAMEX, PRES Paris Sorbonne Cité, France.
Eric Ogier-DenisINSERM, UMRS1149, Team «Physiopathology of Inflammatory Bowel Diseases», Centre de Recherche sur l'Inflammation, Paris, France; Université Paris-Diderot Sorbonne Paris-Cité, Paris, France; Laboratory of Excellence Labex INFLAMEX, PRES Paris Sorbonne Cité, France.
Délégation Paris 7 · FRInserm · FRUniversité Paris Cité · FRCentre de Recherche Jean Pierre Aubert · FRCentre de Recherche sur l'Inflammation · FRSorbonne Paris Cité · FRUniversité Claude Bernard Lyon 1 · FRUniversité de Strasbourg · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ulcerative colitis (UC) is a chronic inflammatory bowel disease affecting the rectum which progressively extents. Its etiology remains unknown and the number of treatments available is limited. Studies of UC patients have identified an unbalanced endoplasmic reticulum (ER) stress in the non-inflamed colonic mucosa. Animal models with impaired ER stress are sensitive to intestinal inflammation, suggesting that an unbalanced ER stress could cause inflammation. However, there are no ER stress-regulating strategies proposed in the management of UC partly because of the lack of relevant preclinical model mimicking the disease. Here we generated the IL10/Nox1dKO mouse model which combines immune dysfunction (IL-10 deficiency) and abnormal epithelium (NADPH oxidase 1 (Nox1) deficiency) and spontaneously develops a UC-like phenotype with similar complications (colorectal cancer) than UC. Our data identified an unanticipated combined role of IL10 and Nox1 in the fine-tuning of ER stress responses in goblet cells. As in humans, the ER stress was unbalanced in mice with decreased eIF2α phosphorylation preceding inflammation. In IL10/Nox1dKO mice, salubrinal preserved eIF2α phosphorylation through inhibition of the regulatory subunit of the protein phosphatase 1 PP1R15A/GADD34 and prevented colitis. Thus, this new experimental model highlighted the central role of epithelial ER stress abnormalities in the development of colitis and defined the defective eIF2α pathway as a key pathophysiological target for UC. Therefore, specific regulators able to restore the defective eIF2α pathway could lead to the molecular remission needed to treat UC.

Indexed as

Disease Models, AnimalEndoplasmic Reticulum StressAnimalsBlotting, WesternCase-Control StudiesCell ProliferationCells, CulturedColitis, UlcerativeColonEndoplasmic ReticulumFemaleFlow CytometryFluorescent Antibody TechniqueHumansImmunoenzyme TechniquesInflammationInterleukin-10NADH, NADPH OxidoreductasesNADPH Oxidase 1NOX1 protein, mousePpp1r15a protein, mouseProtein Phosphatase 1RNA, Messenger

Identifiers

PMID25014110
PMCPMC4090121
OpenAlexW2035604852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.